JNJ - Johnson & Johnson
| Previous close | 127.72 |
| Open | 127.63 |
| Bid | 127.90 x 100 |
| Ask | 127.92 x 200 |
| Day's range | 127.09 - 128.26 |
| 52-week range | 121.35 - 148.32 |
| Volume | 1,901,569 |
| Avg. volume | 8,228,940 |
| Market cap | 342.171B |
| Beta | 0.59 |
| PE ratio (TTM) | 269.09 |
| EPS (TTM) | 0.47 |
| Earnings date | 17 Jul 2018 |
| Forward dividend & yield | 3.36 (2.57%) |
| Ex-dividend date | 2018-02-26 |
| 1y target est | 149.05 |
- Motley Fool•15 hours ago
3 Drugs That Are Moving the Needle at Johnson & Johnson
Johnson & Johnson owes a lot of its early success this year to rapidly growing sales of three key products.
- Barrons.com•18 hours ago
After the Bell: Dow Drops 38 Points Because…IBM
The major equity indexes barely moved today, as a postearnings drop from International Business Machines (IBM) was canceled out by gains from Textron (TXT), Intuitive Surgical (ISRG), and others. Ultimately, it shows once again that it's as much a market of stocks as it is a stock market. The Dow Jones Industrial Average dropped 38.56 points, or 0.2%, to 24,748.07, while the S&P 500 ticked up 0.1% to 2708.64, and the Nasdaq Composite advanced 0.2% to 7295.24.
- MarketWatch•yesterday
IBM and J&J stocks cut 100 points from Dow industrials in early trading
The Dow Jones Industrial Average on Wednesday morning was wrestling with sharp declines in IBM and Johnson & Johnson. Shares of International Business Machines Corp. were off 7.2%, or about $11.50, which equates to a drop of about 80 points, while J&J's stock was contributing a further 24-point retreat in the benchmark, down 2.7%, or about $3.50, in recent action. Overall, the Dow was still managing to rise by about 24 points, or less than 0.1%, at 24,802, with J&J and IBM's tumble slightly offset by gains in Home Depot Inc. Caterpillar Inc. and Boeing Co. 's stocks.
- Bloomberg•2 days ago
What to Look for as First-Quarter Earnings Hit Around the Globe
Trade, taxes and China are the main themes to watch for heading into first-quarter earnings, along with a spate of potential deals.
- Associated Press•2 days ago
UnitedHealth and Alphabet climb; Tesla and Comerica skid
Stocks that moved substantially or traded heavily Tuesday: UnitedHealth Group Inc., up $8.23 to $238.55 The health insurer raised its annual profit forecast after a strong first quarter. Tesla Inc., down ...
- Investor's Business Daily•2 days ago
J&J Boosts Sales Forecast On Growing Demand For Cancer Drugs
Johnson & Johnson nudged its 2018 sales guidance higher Tuesday as demand for cancer drugs surged in the first quarter, even as its blockbuster Remicade continued to face competitive pressure.
- Motley Fool•2 days ago
Why Geron Corporation's Stock Is Heading Higher Today
Geron's experimental blood cancer drug remains a top priority for the pharma behemoth Johnson & Johnson.
Motley Fool•2 days agoJohnson & Johnson (JNJ) Q1 2018 Earnings Conference Call Transcript
JNJ earnings call for the period ending March 31, 2018.
Yahoo Finance•2 days agoStocks surge on earnings, China to ease foreign auto rules
Yahoo Finance's LIVE market coverage and analysis of stocks and bonds begins each day at 11:45 a.m. ET.
- Market Realist•2 days ago
Novartis’s 1Q18: Analysts Expect Revenue Growth
Analysts expect Novartis’s (NVS) revenue to rise ~8.8% to $12.6 billion in 1Q18 following growth in operating revenues across all three of its segments during the quarter.
Associated Press•2 days agoJohnson & Johnson tops 1Q views on sales spike, but net dips
Much-higher spending and one-time charges offset a12.6 percent jump in health care giant Johnson & Johnson's first-quarter revenue, trimming its profit by 1.2 percent, but the results still beat Wall Street ...
- Bloomberg•2 days ago
J&J Lives Up to Its Valuation -- For Now
The risk of disappointment and its reliance on pharma keep growing.
- Zacks•2 days ago
New Construction Data, Q1 Earnings In Focus
New Construction Data, Q1 Earnings In Focus
- Zacks•2 days ago
Tax Day Not So Taxing (for Corporations, Housing)
Strength in Q1 earnings season, at least in these early stages, has helped bolster market indexes. This continues ahead of Tuesday's market open.
- Zacks•2 days ago
J&J (JNJ) Tops Q1 Earnings Estimates, Raises Sales Guidance
J&J (JNJ) beats estimates for both earnings and sales in the first quarter of 2018. It maintains the previously issued earnings guidance for 2018 while increasing the sales range.
- Motley Fool•2 days ago
Zytiga, Stelara Lift Johnson & Johnson's Sales
Find out how the Actelion acquisition also helped produce blockbuster results for the healthcare giant.
- Barrons.com•2 days ago
Morning Movers: Goldman, UnitedHealth Jump on Earnings, Twitter Takes Off on Upgrade
The Dow Jones Industrial Average could open up more than 200 points this morning as investors celebrate solid earnings from the likes of Goldman Sachs (GS), UnitedHealth (UNH) and Johnson & Johnson (JNJ). S&P 500 futures have advanced 0.6%, while Dow Jones Industrial Average futures have gained 200 points, or 0.8%. As we mentioned earlier this morning, the big debate heading into earnings season was whether earnings would be good enough to boost the market.
- Yahoo Finance•2 days ago
Stocks futures push higher, earnings beats continue rolling in
Yahoo Finance's LIVE market coverage and analysis of what you need to watch in the stock market begins each day at 9:25 a.m. ET.
- Investor's Business Daily•2 days ago
Premarket Trading: Blue Chips, Netflix Power Up; China Adds Tariffs
Blue chip names stepped up to help Netflix drive premarket trading Tuesday, as the market's uptrend aimed to break past resistance.
- Financial Times•2 days ago
[$$] US stock futures higher as earning season picks up pace
US stock-index futures are pointing higher on Tuesday as investors draw encouragement from the gathering pace of corporate earnings. S&P 500 futures are up 0.6 per cent this morning, while those for the ...
- Zacks•2 days ago
J&J (JNJ) Beats on Q1 Earnings & Sales, Ups 2018 Sales View
J&J (JNJ) beat estimates for both earnings and sales in the first quarter of 2018. It maintained the previously issued earnings guidance for 2018 while increasing the sales range.
- Bloomberg•2 days ago
Johnson & Johnson CFO Plans for a Strong Year for 2018
Dominic Caruso, chief financial officer at Johnson & Johnson, discusses the company's earnings, outlook and deployment of capital. He speaks with David Westin on "Bloomberg Daybreak: Americas." ...
Associated Press•2 days agoGlobal stocks turn higher on upbeat corporate earnings
Global stocks turned higher on Tuesday after upbeat U.S. corporate earnings reports and robust Chinese economic growth data. KEEPING SCORE: France's CAC 40 was up 0.4 percent to 5,333, while Germany's ...
- GlobeNewswire•2 days ago
New Research: Key Drivers of Growth for Johnson & Johnson, Chesapeake Energy, Visa, Celgene, Adobe, and Markel — Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, April 17, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- Financial Times•2 days ago
[$$] Johnson & Johnson up in pre-market as Q1 results top forecasts
Johnson & Johnson posted quarterly sales and profits that were ahead of Wall Street expectations, sending shares in the healthcare company higher in premarket trading. The world’s largest healthcare company ...
